Synchronous Primary Renal Cell Carcinoma and Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review
This report suggests that the appropriate treatment for this association in metastatic or unresectable disease is chemotherapy for pancreatic cancer and tyrosine kinase inhibitor for kidney cancer. We also review the appropriate literature concerning that association.Case Rep Oncol 2017;10:1050 –1056
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | CT Scan | Hypertension | Jaundice | Kidney Cancer | Pain | Pancreas | Pancreatic Cancer | PET Scan | Renal Cell Carcinoma | Urology & Nephrology | Weight Loss | Xgeva